Gene: UEVLD
Official Full Name: UEV and lactate/malate dehyrogenase domainsprovided by HGNC
Gene Summary: Predicted to enable ubiquitin binding activity. Predicted to be involved in endosome to lysosome transport. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12831 | UEVLD Knockout cell line (HeLa) | Human | UEVLD | 1:3~1:6 | Negative | Online Inquiry |
KO12832 | UEVLD Knockout cell line (HCT 116) | Human | UEVLD | 1:2~1:4 | Negative | Online Inquiry |
KO12833 | UEVLD Knockout cell line (HEK293) | Human | UEVLD | 1:3~1:6 | Negative | Online Inquiry |
KO12834 | UEVLD Knockout cell line (A549) | Human | UEVLD | 1:3~1:4 | Negative | Online Inquiry |
UEVLD Gene Knockout Cell Lines are highly specialized cellular models engineered to lack the expression of the UEVLD gene, which plays a critical role in various biological processes, including immune regulation and cellular signaling pathways. Through targeted gene editing techniques, such as CRISPR-Cas9, these cell lines provide researchers with the ability to investigate the functional consequences of UEVLD deficiency in vitro, allowing for detailed studies of gene function and interactions within cellular environments.
The unique mechanism of action behind UEVLD Gene Knockout Cell Lines enables scientists to easily explore the implications of gene loss on cellular behavior, including proliferation, apoptosis, and response to environmental stimuli. These models can be utilized in diverse research areas, such as cancer biology, immunology, and pharmacology, facilitating the discovery of novel therapeutic targets and enhancing the understanding of disease mechanisms.
The scientific importance of UEVLD Gene Knockout Cell Lines cannot be overstated; they offer a reliable platform for hypothesis-driven research, ultimately leading to improved clinical applications. Compared to traditional cell lines, UEVLD knockout models provide a more accurate representation of gene function in a native cellular context, thus enabling more relevant results that can inform drug development and regenerative medicine applications.
One of the key advantages of our UEVLD Gene Knockout Cell Lines is their ease of use and reproducibility, significantly streamlining the research process. The consistency of these models also ensures that findings can be reliably translated to potential clinical scenarios. For researchers and clinicians focused on gene function and therapeutic intervention strategies, our product stands out as an invaluable resource in advancing scientific knowledge and driving innovation.
As a leader in biological products, our company is committed to supporting the research community with cutting-edge tools designed for precision and excellence. With our expertise in gene editing technologies, we aim to empower researchers to achieve their scientific goals with confidence and clarity.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.